Home » Topics » BioWorld Science

BioWorld Science
RSS

Protective effect demonstrated for FR-167653 against aspirin-induced gastric damage

July 13, 2001

EMEA accepts Oxford GlycoSciences' MAA for Vevesca

July 13, 2001

Sea cucumber-based therapy useful for age-associated dementia

July 13, 2001

MabCampath approved in Europe for B-CLL

July 13, 2001

Lilly Icos seeks European approval of Cialis for treatment of erectile dysfunction

July 13, 2001

Safer anticoagulation obtained with Ro-67-8698, a new factor VIIa inhibitor, than napsagatran

July 13, 2001

Beneficial effects of humanized anti-hTF antibody in hypercoagulable states

July 13, 2001

HTU-PA is a safe and effective thrombolytic agent in acute myocardial infarction

July 13, 2001

Antiplatelet antibody fragment designed at Chinese university

July 13, 2001

Design of mixed direct thrombin and factor Xa inhibitors reported at ISTH

July 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...